•
Jun 30, 2023

Immuneering Q2 2023 Earnings Report

Total Revenue
$94.4M
Previous year: $94.4K
+99900.0%
EPS
-$0.43
Previous year: -$0.44
-2.3%
Cash and Equivalents
$104M
Previous year: $87.9M
+18.3%
Free Cash Flow
-$10.8M
Previous year: -$9.61M
+12.7%
Total Assets
$125M
Previous year: $142M
-12.1%

Immuneering

Immuneering